353 related articles for article (PubMed ID: 23484892)
1. Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women.
Baker JW; Craig TJ; Riedl MA; Banerji A; Fitts D; Kalfus IN; Uknis ME
Allergy Asthma Proc; 2013; 34(2):162-9. PubMed ID: 23484892
[TBL] [Abstract][Full Text] [Related]
2. Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks.
Grant JA; White MV; Li HH; Fitts D; Kalfus IN; Uknis ME; Lumry WR
Allergy Asthma Proc; 2012; 33(4):348-53. PubMed ID: 22856635
[TBL] [Abstract][Full Text] [Related]
3. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.
Riedl MA; Hurewitz DS; Levy R; Busse PJ; Fitts D; Kalfus I
Ann Allergy Asthma Immunol; 2012 Jan; 108(1):49-53. PubMed ID: 22192966
[TBL] [Abstract][Full Text] [Related]
4. Nanofiltered human C1 inhibitor concentrate (Cinryze®): in hereditary angioedema.
Lyseng-Williamson KA
BioDrugs; 2011 Oct; 25(5):317-27. PubMed ID: 21942916
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema.
Lumry W; Soteres D; Gower R; Jacobson KW; Li HH; Chen H; Schranz J
Pediatr Allergy Immunol; 2015 Nov; 26(7):674-80. PubMed ID: 26171584
[TBL] [Abstract][Full Text] [Related]
6. Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children.
Lumry W; Manning ME; Hurewitz DS; Davis-Lorton M; Fitts D; Kalfus IN; Uknis ME
J Pediatr; 2013 May; 162(5):1017-22.e1-2. PubMed ID: 23312695
[TBL] [Abstract][Full Text] [Related]
7. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
Craig TJ; Bewtra AK; Hurewitz D; Levy R; Janss G; Jacobson KW; Packer F; Bernstein JA; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
Allergy Asthma Proc; 2012; 33(4):354-61. PubMed ID: 22856636
[TBL] [Abstract][Full Text] [Related]
8. Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.
Riedl MA; Lumry WR; Li HH; Craig TJ; Fitts D; Kalfus I; Uknis ME
Am J Rhinol Allergy; 2013; 27(6):517-21. PubMed ID: 24274230
[TBL] [Abstract][Full Text] [Related]
9. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
[TBL] [Abstract][Full Text] [Related]
10. Interventions for the long-term prevention of hereditary angioedema attacks.
Beard N; Frese M; Smertina E; Mere P; Katelaris C; Mills K
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013403. PubMed ID: 36326435
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety.
Hofstra JJ; Kleine Budde I; van Twuyver E; Choi G; Levi M; Leebeek FW; de Monchy JG; Ypma PF; Keizer RJ; Huitema AD; Strengers PF
Clin Immunol; 2012 Mar; 142(3):280-90. PubMed ID: 22197071
[TBL] [Abstract][Full Text] [Related]
13. Improving patient outcomes in hereditary angioedema: reducing attack frequency using routine prevention with C1 inhibitor concentrate.
Dominas N; Hoffmann TK; Bas M; Greve J
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24850548
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in patients with hereditary angioedema receiving therapy for routine prevention of attacks.
Lumry WR; Miller DP; Newcomer S; Fitts D; Dayno J
Allergy Asthma Proc; 2014; 35(5):371-6. PubMed ID: 25295804
[TBL] [Abstract][Full Text] [Related]
15. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
[TBL] [Abstract][Full Text] [Related]
17. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
Bork K
Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
[TBL] [Abstract][Full Text] [Related]
18. C1-esterase inhibitor (Cinryze
Gupta R; Balduzzi J; Davis-Lorton M
Immunotherapy; 2018 Jun; 10(8):635-642. PubMed ID: 29569504
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
Riedl M
Clin Drug Investig; 2015 Jul; 35(7):407-17. PubMed ID: 26091744
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.
Riedl MA; Li HH; Cicardi M; Harper JR; Relan A
Allergy Asthma Proc; 2017 Nov; 38(6):462-466. PubMed ID: 28903805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
